APA (7th ed.) Citation

V, B., J, L., P, O., JK, K., V, G., M, K., . . . KM, D. (2025). Targeting Cdc42 improves motor phenotype in Parkinson's disease mice and reveals age-dependent susceptibility to α-synuclein. IScience, 28(12), 114217. https://doi.org/10.1016/j.isci.2025.114217

Chicago Style (17th ed.) Citation

V, Bopp, et al. "Targeting Cdc42 Improves Motor Phenotype in Parkinson's Disease Mice and Reveals Age-dependent Susceptibility to α-synuclein." IScience 28, no. 12 (2025): 114217. https://doi.org/10.1016/j.isci.2025.114217.

MLA (9th ed.) Citation

V, Bopp, et al. "Targeting Cdc42 Improves Motor Phenotype in Parkinson's Disease Mice and Reveals Age-dependent Susceptibility to α-synuclein." IScience, vol. 28, no. 12, 2025, p. 114217, https://doi.org/10.1016/j.isci.2025.114217.